Skip Navigation

European Heart Journal 2000 21(10):792-793; doi:10.1053/euhj.1999.2073
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by van der Werf, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Werf, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Should we transfer patients with acute myocarial infarcation to a tertiary care hospital for primary angioplasty?

F. van der Werf

Gasthuisberg University Hospital, Leuven, Belgium

References

  1. Weaver WD, Simes RJ, Betriu A. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093–2098[Abstract]
  2. Widimský P, Groch L, elizko M, Aschermann M, Bedná F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without catheterization. Eur Heart J. 2000;21:823–831[Abstract/Free Full Text]
  3. Ross AM. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol. 1999;34:1954–1962[Abstract/Free Full Text]
  4. Gurbel PA, Serebruany VL, Shustov AR. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. J Am Coll Cardiol. 1998;31:1466–1473[Abstract/Free Full Text]
  5. Antman E, Giugliano RP, Gibson MC. Abciximab facilitates the rate and extent of thrombolysis. Results of the TIMI 14 trial. Circulation. 1999;99:2720–2732[Abstract/Free Full Text]
  6. Topol, EJ, The SPEED trial, presented at the XXIst Congress of the European Society of Cardiology, Barcelona, 1999

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by van der Werf, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Werf, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?